Prestwich Pharmacy Limited - Limited company - abbreviated - 11.0.0
Prestwich Pharmacy Limited - Limited company - abbreviated - 11.0.0
| REGISTERED NUMBER: |
| Abbreviated Unaudited Accounts for the Year Ended 31 October 2013 |
| for |
| PRESTWICH PHARMACY LIMITED |
| PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939) |
| Contents of the Abbreviated Accounts |
| for the Year Ended 31 October 2013 |
| Page |
| Company Information | 1 |
| Abbreviated Balance Sheet | 2 |
| Notes to the Abbreviated Accounts | 4 |
| PRESTWICH PHARMACY LIMITED |
| Company Information |
| for the Year Ended 31 October 2013 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| BANKERS: |
| PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939) |
| Abbreviated Balance Sheet |
| 31 October 2013 |
| 31.10.13 | 31.10.12 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 2 |
| Investments | 3 |
| CURRENT ASSETS |
| Stocks |
| Debtors |
| Prepayments and accrued income |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 4 |
| Share premium |
| Profit and loss account |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939) |
| Abbreviated Balance Sheet - continued |
| 31 October 2013 |
| The financial statements were approved by the Board of Directors on |
| PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939) |
| Notes to the Abbreviated Accounts |
| for the Year Ended 31 October 2013 |
| 1. | ACCOUNTING POLICIES |
| Accounting convention |
| The financial statements have been prepared under the historical cost convention and in accordance with the |
| Financial Reporting Standard for Smaller Entities (effective April 2008). |
| Turnover |
| Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration |
| in exchange for its performance of its obligations under the sales contract with the customer. The amount |
| reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual |
| arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties. |
| Tangible fixed assets |
| Improvements to property | - |
| Plant and machinery | - |
| Fixtures and fittings | - |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and |
| slow moving items. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the |
| balance sheet date. |
| Hire purchase and leasing commitments |
| Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the |
| period of the lease. |
| Financial instruments |
| Financial instruments are classified and accounted for, according to the substance of the contractual |
| arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any |
| contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. |
| Deferred government grants |
| Deferred government grants in respect of capital expenditure are treated as deferred income and are credited to |
| the profit and loss account over the estimated useful life of the assets to which they relate. |
| 2. | TANGIBLE FIXED ASSETS |
| Total |
| £ |
| COST |
| At 1 November 2012 |
| Additions |
| At 31 October 2013 |
| DEPRECIATION |
| At 1 November 2012 |
| Charge for year |
| At 31 October 2013 |
| NET BOOK VALUE |
| At 31 October 2013 |
| At 31 October 2012 |
| PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939) |
| Notes to the Abbreviated Accounts - continued |
| for the Year Ended 31 October 2013 |
| 3. | FIXED ASSET INVESTMENTS |
| Investments |
| other |
| than |
| loans |
| £ |
| COST |
| At 1 November 2012 |
| and 31 October 2013 | 162,981 |
| NET BOOK VALUE |
| At 31 October 2013 |
| At 31 October 2012 |
| The company's investments at the balance sheet date in the share capital of companies include the following: |
| Nature of business: |
| % |
| Class of shares: | holding |
| Ordinary shares of £1 each | 100.00 |
| £ | £ |
| Aggregate capital and reserves | 255,649 | 255,649 |
| The investment represents the purchase of 100% of the issued ordinary share capital of Hughes McCaul |
| Limited, a company incorporated in England and Wales. The shares purchased are 600,100 ordinary shares of |
| £1 each. |
| Consolidated accounts for the group have not been prepared on the grounds that the group qualifies as a small |
| group under the Companies Act 2006. |
| 4. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.10.13 | 31.10.12 |
| value: | £ | £ |
| Ordinary A | £1 |
| Ordinary B | £1 |
| Ordinary C | £1 |
| Ordinary D | £1 |
| Ordinary E | £1 |
| 10,004 | 10,004 |